Podiatry Arena members do not see these ads

Is there any cosensus of opinion on how a neurothesiometer should be used, and what points of the foot should be tested?
I have been unable to find any literature on this subject.

I stand to be corrected, but I don't think that there is any evidence to support what location(s) should be tested for VPT with the neurothesiometer or biothesiometer. There have been several sensitivity and specificity studies on locations with the monofilament.

However, I just use medial 1st MPJ, lateral 5th MPJ and medial maleolus.

__________________
Craig Payne
Department of Podiatry
La Trobe University
Melbourne, Australia
http://www.latrobe.edu.au/podiatry
__________________________________________________ ___________________________________
God put me on this earth to accomplish a certain number of things - right now I am so far behind, I will never die.
The views expressed above are those of the author and not that of La Trobe University
This is where I am, where are you?

Dear AALang,

See references below.

Best regards ,

Sosenko JM, Kato M, Soto R, Bild DE.
Comparison of quantitative sensory-threshold measures for their association with foot ulceration in diabetic patients.
Diabetes Care. 1990 Oct;13(10):1057-61.
PMID: 2209302 [PubMed - indexed for MEDLINE]

J.P. Cassella, R.L. Ashford, V. Kavanagh-Sharp
Effect of applied pressure in the determination of vibration
sensitivity using the Neurothesiometer
The Foot (2000) 10, 27–30

Armstrong DG, Lavery LA, Vela SA, Quebedeaux TL, Fleischli JG.
Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration.
Arch Intern Med. 1998 Feb 9;158(3):289-92.
PMID: 9472210 [PubMed - indexed for MEDLINE]

Armstrong DG, Hussain SK, Middleton J, Peters EJ, Wunderlich RP, Lavery LA.
Vibration perception threshold: are multiple sites of testing superior to single site testing on diabetic foot examination?
Ostomy Wound Manage. 1998 May;44(5):70-4, 76.
PMID: 9697548 [PubMed - indexed for MEDLINE]

Hagander LG, Midani HA, Kuskowski MA, Parry GJ.
Quantitative sensory testing: effect of site and pressure on vibration thresholds.
Clin Neurophysiol. 2000 Jun;111(6):1066-9.
PMID: 10825714 [PubMed - indexed for MEDLINE]

Kastenbauer T, Sauseng S, Brath H, Abrahamian H, Irsigler K.
The value of the Rydel-Seiffer tuning fork as a predictor of diabetic polyneuropathy compared with a neurothesiometer.
Diabet Med. 2004 Jun;21(6):563-7.
PMID: 15154940 [PubMed - indexed for MEDLINE]

Chong PS, Cros DP.
Technology literature review: quantitative sensory testing.
Muscle Nerve. 2004 May;29(5):734-47. Review.
PMID: 15116380 [PubMed - indexed for MEDLINE]

Gin H, Rigalleau V, Baillet L, Rabemanantsoa C.
Comparison between monofilament, tuning fork and vibration perception tests for screening patients at risk of foot complication.
Diabetes Metab. 2002 Dec;28(6 Pt 1):457-61.
PMID: 12522325 [PubMed - indexed for MEDLINE]

Jirkovska A, Boucek P, Woskova V, Bartos V, Skibova J.
Identification of patients at risk for diabetic foot: a comparison of standardized noninvasive testing with routine practice at community diabetes clinics.
J Diabetes Complications. 2001 Mar-Apr;15(2):63-8.
PMID: 11274901 [PubMed - indexed for MEDLINE]

Mayfield JA, Sugarman JR.
The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in persons with diabetes.
J Fam Pract. 2000 Nov;49(11 Suppl):S17-29. Review.
PMID: 11093555 [PubMed - indexed for MEDLINE]